VX-702, CAS 745833-23-2

Description: VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).

CAS Number: 745833-23-2

Formula: C19H12F4N4O2

Molecular Weight: 404,32

References: Kuliopulos A, et al. Thromb Haemost, 2004, 92(6), 1387-1393.

• Artikelnummer: TGMT2513-50mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T2513-50mg
• Verpackungseinheit: 50 mg
• Mengeneinheit: STK